Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer

Clinical trial NCT00741195 · COMPLETED

Trial details

NCT number: NCT00741195
Sponsor: Hellenic Oncology Research Group
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer

Start date: 2008-04-01
Primary completion: 2016-10-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.